New research suggests that Down's syndrome could be detected using genetic screening, avoiding the need for invasive detection procedures.
The study found that it was possible to sequence the DNA collected from blood samples of mothers at high risk of a pregnancy with Down's syndrome. The authors claim that using maternal blood tests would avoid the need for 98 percent of more invasive procedures.
Down's syndrome occurs when there are three copies of either all or part of chromosome 21, instead of the normal two. Individuals with the condition often have learning difficulties.
The team from the University of Hong Kong compared two 'multiplex' DNA (genetic) sequencing methods in a total of 1,067 pregnancies. These techniques allow the detection of large additions of genetic material that can occur in chromosome 21. They found that the most sensitive method was able to predict Down's syndrome positively in 96.6 percent of cases and negatively in one hundred percent of cases.
Currently Down's syndrome is detected using either amniocentesis or CVS (chorionic villus sampling), which involve taking a sample from the amniotic fluid or placenta respectively, which can increase the risk of miscarriage by around one percent. These tests are still used in three to five percent of pregnancies in the UK, when combination scans and hormone level tests indicate that a mother is at an increased risk of their unborn child developing Down's syndrome.
The scientists concluded that this technique could be used to test for Down's syndrome in high-risk pregnancies, and therefore avoid 98 percent of invasive tests.
The findings were published online in the British Medical Journal (BMJ).
Sources and References
Related Articles
Down's syndrome chromosome 'can be silenced'
A method that 'switches off' entire chromosomes has been used in isolated cells to target the genetic defect behind Down's syndrome...
Fetal genome sequenced using only a blood sample from the mother
US researchers have for the first time sequenced the genome of a fetus using only a blood sample from the mother. It is hoped this new form of non-invasive sampling could allow doctors to screen for a range of genetic diseases prenatally, with minimal risk to the fetus...
Safer prenatal test for Down's syndrome launched in US
A new prenatal test that can detect Down's syndrome by using a sample of the mother's blood was launched in twenty US cities last Monday....
Fetal DNA scanned for disease
Scientists have scanned the entire DNA of an unborn child from the mother's blood sample for the first time to safely check for genetic disorders...
New PGD technology guidelines published for the genetic testing of IVF embryos
The European Society of Human Reproduction and Embryology (ESHRE) has published an updated set of best practice guidelines for fertility clinics on the use of preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS) techniques...
Newborns to be screened for genetic conditions
Newborn babies showing signs of liver disorders will be screened for 92 genetic conditions, as part of a trial launching next month at Birmingham Children's Hospital. Newborns will be screened for multiple conditions with a single test using gene chip technology....
Cell-free fetal DNA: testing the waters
A decade ago, it was found that the blood of pregnant women contains DNA from the fetus. The discovery of this 'free fetal DNA' (ffDNA) has led to the development of non-invasive prenatal diagnosis, where genetic characteristics of the fetus can be analysed a mere few weeks into pregnancy by...